Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways

Figure 4

In vivo effect of oridonin on tumorigenicity in T24 xenograft tumor model mice. (a) Representative images of T24 tumor-bearing mice given different treatments for 23 days. (b) Flank tumors resected from mice bearing T24 xenograft tumors. (c) Tumor volume curves of T24 xenograft model mice under different treatments (). (d) Tumor weight curve of T24 xenograft model mice under different treatments ().

(a)

(b)

(c)

(d)